Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 May 12;91(11):e02065-16. doi: 10.1128/JVI.02065-16

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2017 American Society for Microbiology.

All Rights Reserved.

PMC Copyright notice

FIG 7 — In vivo efficacy of cAbs 65C6/IgG2a, 65C6/D265A, 100F4/IgG2a, and 100F4/D265A in minimum protective doses against the lethal challenge of virus strains SZ06, SX06, and NE14. (A to F) Time course of body weight changes (top panels) and survival rate of each group (bottom panels) against SZ06 (A and D), NE14 (B and E), and SX06 (C and F) by 100F4/IgG2a and 100F4/D265A cAbs (A to C) and by 65C6/IgG2a and 65C6/D265A cAbs (D to F) along with VRC01 control antibody. The survival rate was calculated as percent survival within each experimental group (five mice in each group).